Summary Bausch & Lomb Incorporated (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International, Inc., is a global healthcare company. It develops, manufactures and markets eye health products for a wide range of eye conditions including glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. Bausch & Lomb offers contact lenses, contact lens care, dry eye products, allergy/redness relief, Rx Pharmaceutical, eye vitamins, surgical products, vision accessories and safety and industrial cleaning products. The company has a manufacturing facility in Tampa, Florida, the US. It has a presence in Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Bausch & Lomb Incorporated - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Bausch & Lomb Incorporated Company Snapshot 6 Bausch & Lomb Incorporated Company Overview 6 Bausch & Lomb Incorporated Pipeline Products and Clinical Trials Overview 7 Bausch & Lomb Incorporated - Pipeline Analysis Overview 9 Business Description 9 Key Facts 10 Bausch & Lomb Incorporated - Major Products and Services 11 Bausch & Lomb Incorporated Pipeline Products by Development Stage 13 Bausch & Lomb Incorporated Pipeline Products Overview 15 Cirle 3-D Surgical Navigation System 15 Cirle 3-D Surgical Navigation System Product Overview 15 Customlens 16 Customlens Product Overview 16 Customshape 17 Customshape Product Overview 17 Sarfarazi Elliptical Accommodating IOL 18 Sarfarazi Elliptical Accommodating IOL Product Overview 18 Ultra Multi Focal Lens 19 Ultra Multi Focal Lens Product Overview 19 Ultra Plus Powers Lens 20 Ultra Plus Powers Lens Product Overview 20 Ultra Toric Lens 21 Ultra Toric Lens Product Overview 21 Bausch & Lomb Incorporated - Key Competitors 22 Bausch & Lomb Incorporated - Key Employees 23 Bausch & Lomb Incorporated - Key Employee Biographies 24 Bausch & Lomb Incorporated - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Recent Developments 27 Bausch & Lomb Incorporated, Recent Developments 27 Nov 11, 2015: Bausch + Lomb Presents Products, Surgical Platforms and Newly Expanded Retina Offerings During the Annual Meeting of the American Academy of Ophthalmology in Las Vegas 27 Nov 10, 2015: Bausch + Lomb Announces 2016 Launch of Bausch + Lomb ULTRA Contact Lenses for Presbyopia 29 Oct 08, 2015: Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation 30 Oct 02, 2015: Cirle Receives Prestigious 2015 Red Dot Design Concept Award for Its 3-D Surgical Navigation System 31 Sep 17, 2015: Bausch + Lomb's Adjustable Chandelier Fiber for the Stellaris PC Vision Enhancement System Receives FDA Clearance 31 Aug 12, 2015: Bausch + Lomb Announces 23-Gauge Fragmentation Needle Availability for Stellaris PC Vision Enhancement System 32 Aug 03, 2015: Bausch + Lomb's VICTUS Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Enhanced Patient Interface Kit 32 Jul 29, 2015: Bausch + Lomb Announces Appointment of Brian Rosenblatt, OD, to Professional Strategy Team for US Vision Care Business 33 Jul 28, 2015: Valeant Pharmaceuticals Presented with Economic Development Support from Rochester Gas & Electric for the Bausch + Lomb ULTRA Contact Lens Manufacturing Line Expansion in Rochester, NY 34 Jun 23, 2015: Bausch + Lomb's Biotrue ONEday for Presbyopia Contact Lenses Now Available in Expanded High Add Powers 34 Appendix 36 Methodology 36 About GlobalData 36 Contact Us 36 Disclaimer 36
List of Tables
Bausch & Lomb Incorporated Pipeline Products and Clinical Trials Overview 7 Bausch & Lomb Incorporated Pipeline Products by Equipment Type 7 Bausch & Lomb Incorporated Pipeline Products by Indication 8 Bausch & Lomb Incorporated, Key Facts 10 Bausch & Lomb Incorporated, Major Products and Services 11 Bausch & Lomb Incorporated Number of Pipeline Products by Development Stage 13 Bausch & Lomb Incorporated Pipeline Products Summary by Development Stage 14 Cirle 3-D Surgical Navigation System - Product Status 15 Cirle 3-D Surgical Navigation System - Product Description 15 Customlens - Product Status 16 Customlens - Product Description 16 Customshape - Product Status 17 Customshape - Product Description 17 Sarfarazi Elliptical Accommodating IOL - Product Status 18 Sarfarazi Elliptical Accommodating IOL - Product Description 18 Ultra Multi Focal Lens - Product Status 19 Ultra Multi Focal Lens - Product Description 19 Ultra Plus Powers Lens - Product Status 20 Ultra Plus Powers Lens - Product Description 20 Ultra Toric Lens - Product Status 21 Ultra Toric Lens - Product Description 21 Bausch & Lomb Incorporated, Key Employees 23 Bausch & Lomb Incorporated, Key Employee Biographies 24 Bausch & Lomb Incorporated, Other Locations 25 Bausch & Lomb Incorporated, Subsidiaries 25
List of Figures
Bausch & Lomb Incorporated Pipeline Products by Equipment Type 8 Bausch & Lomb Incorporated Pipeline Products by Development Stage 13
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.